Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
https://arstechnica.com/science/2022/11/gene-editing-used-in-new-clinical-trial-against-cancer/
0
0
How researchers used CRISPR gene editing to send immune cells after cancer - Ars Technica
11/14/22 at 8:54pm
Organization
Ars Technica
Author
John Timmer
29 words
0
Comments
New trial has limited effect on cancer, but technology is likely to see further use.
Health
Biological Sciences
Cancer
CRISPR
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...